Odevixibat
A4250-016
Phase 3 small_molecule active
Quick answer
Odevixibat for Biliary Atresia is a Phase 3 program (small_molecule) at Ipsen with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ipsen
- Indication
- Biliary Atresia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active